East China Pharmaceutical (002675.SZ): The application for the listing of the raw material drug Bemiparin Sodium has been accepted.

Zhitong Financial APP News, Dongcheng Pharmaceutical (002675.SZ) announced that it recently received the "Acceptance Notification" from the National Medical Products Administration regarding the application for the market approval of the active pharmaceutical ingredient Bemiparin Sodium. Bemiparin Sodium is a low molecular weight heparin, and its formulation is Bemiparin Sodium injection, which is used to prevent coagulation during extracorporeal circulation in hemodialysis, as well as to prevent thromboembolic diseases in patients undergoing general surgery and orthopedic surgery.